Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS

Journal of Leukocyte Biology

Volumn 84, Issue 1, 2008, Pages 1-26

  Iannello, Alexandre ^b   Debbeche, Olfa ^b   Samarani, Suzanne ^b   Ahmad, Ali ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b NONE

Author keywords

CD94 NKG2; Chemokines; Cytokines; HIV 1; HLA; KIR; KIR haplotypes; MHC class I; MICA; MICB; NKG2D; ULBP

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; HLA ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; INTERLEUKIN 21; MAJOR HISTOCOMPATIBILITY ANTIGEN; NATURAL KILLER CELL RECEPTOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CELL ACTIVATION; CELL ADHESION; CELL DIFFERENTIATION; CELL SURFACE; CONJUGATION; CYTOKINE PRODUCTION; CYTOSKELETON; DISEASE COURSE; GENE STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOBIOLOGY; IMMUNOTHERAPY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; VIRUS RESISTANCE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; DISEASE PROGRESSION; DRUG RESISTANCE, VIRAL; HIV INFECTIONS; HUMANS; KILLER CELLS, NATURAL; RECEPTORS, IMMUNOLOGIC;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 46949088469     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0907650     Document Type: Review

References (194)

1. Iannello, A., Debbeche, O., Martin, E., Attalah, L. H., Samarani, S., Ahmad, A. (2006) Viral strategies for evading antiviral cellular immune responses of the host. J. Leukoc. Biol. 79, 16-35.
2. Andoniou, C. E., Andrews, D. M., Degli-Esposti, M. A. (2006) Natural killer cells in viral infection: more than just killers. Immunol. Rev. 214, 239-250.
3. Orange, J. S. (2002) Human natural killer cell deficiencies and susceptibility to infection. Microbes Infect. 4, 1545-1558.
4. Di Santo, J. P., Vosshenrich, C. A. J. (2006) Bone marrow versus thymic pathways of natural killer cell development. Immunol. Rev. 214, 35-46.
5. Freud, A. G., Caligiuri, M. A. (2006) Human natural killer cell development. Immunol. Rev. 214, 56-72.
6. Bendelac, A., Savage, P. B., Teyton, L. (2007) The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336.
7. Van Kaer, L. (2007) NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19, 354-364.
8. Cooper, M. A., Fehniger, T. A., Turner, S. C., Chen, K. S., Ghaheri, B. A., Ghayur, T., Carson, W. E., Caligiuri, M. A. (2001) Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset. Blood 97, 3146-3151.
9. Farag, S. S., Fehniger, T. A., Ruggeri, L., Velardi, A., Caligiuri, M. A. (2002) Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect. Blood 100, 1935-1947.
10. Hanna, J., Mussaffi, H., Steuer, G., Hanna, S., Deeb, M., Blau, H., Arnon, T. I., Weizman, N., Mandelboim, O. (2005) Functional aberrant expression of CCR2 receptor on chronically activated NK cells in patients with TAP-2 deficiency. Blood 106, 3465-3473.
11. Keskin, D. B., Allan, D. S. J., Rybalov, B., Andzelm, M. M., Stern, J. N. H., Kopcow, H. D., Koopman, L. A., Strominger, J. L. (2007) TGFβ promotes conversion of CD16+ peripheral blood NK cells into CD16-NK cells with similarities to decidual NK cells. Proc. Natl. Acad. Sci. USA 104, 3378-3383.
12. Romagnani, C., Juelke, K., Falco, M., Morandi, B., D'Agostino, A., Costa, R., Ratto, G., Forte, G., Carrega, P., Lui, G., Conte, R., Strowig, T., Moretta, A., Munz, C., Thiel, A., Moretta, L., Ferlazzo, G. (2007) CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation. J. Immunol. 178, 4947-4955.
13. Takahashi, E., Kuranaga, N., Satoh, K., Habu, Y., Shinomiya, N., Asano, T., Seki, S., Hayakawa, M. (2007) Induction of CD16+ CD56bright NK cells with antitumour cytotoxicity not only from CD16- CD56bright NK cells but also from CD16- CD56dim NK cells. Scand. J. Immunol. 65, 126-138.
14. Ahmad, A., Ahmad, R. (2003) HIV evasion of host NK cell response and novel ways of its countering and boosting anti-HIV immunity. Curr. HIV Res. 1, 295-307.
15. Guidotti, L. G., Chisari, F. V. (2001) Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19, 65-91.
16. Zhang, A. L., Colmenero, P., Purath, U., Teixeira de Matos, C., Hueber, W., Klareskog, L., Tarner, I. H., Engleman, E. G., Soderstrom, K. (2007) Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood 110, 2484-2493.
17. Geldhof, A. B., Van Ginderachter, J. A., Liu, Y., Noel, W., Raes, G., De Baetselier, P. (2002) Antagonistic effect of NK cells on alternatively activated monocytes: a contribution of NK cells to CTL generation. Blood 100, 4049-4058.
18. Nedvetzki, S., Sowinski, S., Eagle, R. A., Harris, J., Vely, F., Pende, D., Trowsdale, J., Vivier, E., Gordon, S., Davis, D. M. (2007) Reciprocal regulation of human natural killer cells and macrophages associated with distinct immune synapses. Blood 109, 3776-3785.
19. Chan, C. W., Crafton, E., Fan, H-N., Flook, J., Yoshimura, K., Skarica, M., Brockstedt, D., Dubensky, T. W., Stins, M. F., Lanier, L. L., Pardoll, D. M., Housseau, F. (2006) Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12, 207-213.
20. Hanna, J., Mandelboim, O. (2007) When killers become helpers. Trends Immunol. 28, 201-206.
21. Taieb, J., Chaput, N., Menard, C., Apetoh, L., Ullrich, E., Bonmort, M., Pequignot, M., Casares, N., Terme, M., Flament, C., Opolon, P., Lecluse, Y., Metivier, D., Tomasello, E., Vivier, E., Ghiringhelli, F., Martin, F., Klatzmann, D., Poynard, T., Tursz, T., Raposo, G., Yagita, H., Ryffel, B., Kroemer, G., Zitvogel, L. (2006) A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12, 214-219.
22. Vosshenrich, C. A. J., Lesjean-Pottier, S., Hasan, M., Richard-Le Goff, O., Corcuff, E., Mandelboim, O., Di Santo, J. P. (2007) CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 204, 2569-2578.
23. Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., Kalinski, P. (2005) IL-18-induced CD83+CCR7+ NK helper cells. J. Exp. Med. 202, 941-953.
24. Tanaka, F., Hashimoto, W., Okamura, H., Robbins, P. D., Lotze, M. T., Tahara, H. (2000) Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells. Cancer Res. 60, 4838-4844.
25. Lu, L., Ikizawa, K., Hu, D., Werneck, M. B. F., Wucherpfennig, K. W., Cantor, H. (2007) Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway. Immunity 26, 593-604.
26. Vankayalapati, R., Klucar, P., Wizel, B., Weis, S. E., Samten, B., Safi, H., Shams, H., Barnes, P. F. (2004) NK cells regulate CD8+ T cell effector function in response to an intracellular pathogen. J. Immunol. 172, 130-137.
27. Gao, N., Dang, T., Yuan, D. (2001) IFN-γ-dependent and -independent initiation of switch recombination by NK cells. J. Immunol. 167, 2011-2018.
28. Takahashi, K., Miyake, S., Kondo, T., Terao, K., Hatakenaka, M., Hashimoto, S., Yamamura, T. (2001) Natural killer type 2 bias in remission of multiple sclerosis. J. Clin. Invest. 107, R23-R29.
29. Wei, H., Zhang, J., Xiao, W., Feng, J., Sun, R., Tian, Z. (2005) Involvement of human natural killer cells in asthma pathogenesis: natural killer 2 cells in type 2 cytokine predominance. J. Allergy Clin. Immunol. 115, 841-847.
30. O'Leary, J. G., Goodarzi, M., Drayton, D. L., von Andrian, U. H. (2006) T cell- and B cell-independent adaptive immunity mediated by natural killer cells. Nat. Immunol. 7, 507-516.
31. Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., Moffett, A. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965.
32. Yan, W. H., Lin, A., Chen, B. G., Zhou, M. Y., Dai, M. Z., Chen, X J., Gan, L. H., Zhu, M., Shi, W. W., Li, B. L. (2007) Possible roles of KIR2DL4 expression on uNK cells in human pregnancy. Am. J. Reprod. Immunol. 57, 233-242.
33. Biron, C. A., Nguyen, K. B., Pien, G. C., Cousens, L. P., Salazar-Mather, T. P. (1999) Natural killer cells in antiviral defense: function and regulation by innate cytokines. Annu. Rev. Immunol. 17, 189-220.
34. Ahmad, A., Ahmad, R., Iannello, A., Toma, E., Morisset, R., Sindhu, S. (2005) IL-15 and HIV infection: lessons for immunotherapy and vaccination. Curr. HIV Res. 3, 261-270.
35. Chalifour, A., Jeannin, P., Gauchat, J-F., Blaecke, A., Malissard, M., N'Guyen, T., Thieblemont, N., Delneste, Y. (2004) Direct bacterial protein PAMP recognition by human NK cells involves TLRs and triggers {α}-defensin production. Blood 104, 1778-1783.
36. Schmidt, K. N., Leung, B., Kwong, M., Zarember, K. A., Satyal, S., Navas, T. A., Wang, F., Godowski, P. J. (2004) APC-independent activation of NK cells by the Toll-like receptor 3 agonist double-stranded RNA. J. Immunol. 172, 138-143.
37. Alter, G., Suscovich, T. J., Teigen, N., Meier, A., Streeck, H., Brander, C., Altfeld, M. (2007) Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J. Immunol. 178, 7658-7666.
38. Baratin, M., Roetynck, S., Lepolard, C., Falk, C., Sawadogo, S., Uematsu, S., Akira, S., Ryffel, B., Tiraby, J-G., Alexopoulou, L., Kirschning, C. J., Gysin, J., Vivier, E., Ugolini, S. (2005) Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum. Proc. Natl. Acad. Sci. USA 102, 14747-14752.
39. Hart, O. M., Athie-Morales, V., O'Connor, G. M., Gardiner, C. M. (2005) TLR7/8-mediated activation of human NK cells results in accessory cell-dependent IFN-{γ} production. J. Immunol. 175, 1636-1642.
40. Mandelboim, O., Lieberman, N., Lev, M., Paul, L., Arnon, T. I., Bushkin, Y., Davis, D. M., Strominger, J. L., Yewdell, J. W., Porgador, A. (2001) Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409, 1055-1060.
41. Arase, H., Arase, N., Saito, T. (1995) Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 181, 1235-1238.
42. Zamai, L., Ahmad, M., Bennett, I. M., Azzoni, L., Alnemri, E. S., Perussia, B. (1998) Natural killer (NK) cell-mediated cytotoxicity: differential use of TRAIL and Fas ligand by immature and mature primary human NK cells. J. Exp. Med. 188, 2375-2380.
43. Ahmad, A., Alvarez, F. (2004) Role of NK and NKT cells in the immunopathogenesis of HCV-induced hepatitis. J. Leukoc. Biol. 76, 743-759.
44. Bryceson, Y. T., March, M. E., Barber, D. F., Ljunggren, H-G., Long, E. O. (2005) Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells. J. Exp. Med. 202, 1001-1012.
45. MacFarlane IV, A. W., Campbell, K. (2006) Signal transduction in natural killer cells. Curr. Top. Microbiol. Immunol. 298, 23-57.
46. Davis, D. M., Dustin, M. L. (2004) What is the importance of the immunological synapse? Trends Immunol. 25, 323-327.
47. Wulfing, C., Purtic, B., Klem, J., Schatzle, J. D. (2003) Stepwise cytoskeletal polarization as a series of checkpoints in innate but not adaptive cytolytic killing. Proc. Natl. Acad. Sci. USA 100, 7767-7772.
48. Davis, D. M. (2007) Intercellular transfer of cell-surface proteins is common and can affect many stages of an immune response. Nat. Rev. Immunol. 7, 238-243.
49. McCann, F. E., Eissmann, P., Onfelt, B., Leung, R., Davis, D. M. (2007) The activating NKG2D ligand MHC class I-related chain a transfers from target cells to NK cells in a manner that allows functional consequences. J. Immunol. 178, 3418-3426.
50. Onfelt, B., Purbhoo, M. A., Nedvetzki, S., Sowinski, S., Davis, D. M. (2005) Long-distance calls between cells connected by tunneling nanotubules. Sci. STKE 2005, pe55.
51. Khakoo, S. I., Carrington, M. (2006) KIR and disease: a model system or system of models? Immunol. Rev. 214, 186-201.
52. Long, E. O. (1999) Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17, 875-904.
53. Lanier, L. L. (2005) NK cell recognition. Annu. Rev. Immunol. 23, 225-274.
54. Lanier, L. L. (1998) NK cell receptors. Annu. Rev. Immunol. 16, 359-393.
55. Kim, J., Chwae, Y. J., Kim, M. Y., Choi, I. H., Park, J. H., Kim, S. J. (1997) Molecular basis of HLA-C recognition by p58 natural killer cell inhibitory receptors. J. Immunol. 159, 3875-3882.
56. Winter, C. C., Long, E. (1997) A single amino acid in the p58 killer cell inhibitory receptor controls the ability of natural killer cells to discriminate between the two groups of HLA-C allotypes. J. Immunol. 158, 4026-4028.
57. Winter, C. C., Gumperz, J. E., Parham, P., Long, E. O., Wagtmann, N. (1998) Direct binding and functional transfer of NK cell inhibitory receptors reveal novel patterns of HLA-C allotype recognition. J. Immunol. 161, 571-577.
58. Biassoni, R., Falco, M., Cambiaggi, A., Costa, P., Verdiani, S., Pende, D., Conte, R., Di Donato, C., Parham, P., Moretta, L. (1995) Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones. J. Exp. Med. 182, 605-609.
59. Faure, M., Long, E. O. (2002) KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential. J. Immunol. 168, 6208-6214.
60. Goodridge, J. P., Witt, C. S., Christiansen, F. T., Warren, H. S. (2003) KIR2DL4 (CD158d) genotype influences expression and function in NK cells. J. Immunol. 171, 1768-1774.
61. Kikuchi-Maki, A., Catina, T. L., Campbell, K. S. (2005) Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor {γ} protein. J. Immunol. 174, 3859-3863.
62. Kikuchi-Maki, A., Yusa, S-i., Catina, T. L., Campbell, K. S. (2003) KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-{γ} production. J. Immunol. 171, 3415-3425.
63. Rajagopalan, S., Bryceson, Y. T., Kuppusamy, S. P., Geraghty, D. E., van der Meer, A., Joosten, I., Long, E. O. (2006) Activation of NK cells by an endocytosed receptor for soluble HLA-G. PLoS Biol. 4, e9.
64. Rajagopalan, S., Fu, J., Long, E. O. (2001) Cutting edge: induction of IFN-{γ} production but not cytotoxicity by the killer cell Ig-like receptor KIR2DL4 (CD158d) in resting NK cells. J. Immunol. 167, 1877-1881.
65. Sargent, I. L., Borzychowski, A. M., Redman, C. W. G. (2006) NK cells and human pregnancy - an inflammatory view. Trends Immunol. 27, 399-404.
66. Gomez-Lozano, N., Pablo, R., Puente, S., Vilches, C. (2003) Recognition of HLA-G by the NK cell receptor KIR2DL4 is not essential for human reproduction. Eur. J. Immunol. 33, 639-644.
67. Gómez-Lozano, N., Gardiner, C., Parham, P., Vilches, C. (2002) Some human KIR haplotypes contain two KIR2DL5 genes: KIR2DL5A and KIR2DL5B. Immunogenetics 54, 314-319.
68. Estefania, E., Flores, R., Gomez-Lozano, N., Aguilar, H., Lopez-Botet, M., Vilches, C. (2007) Human KIR2DL5 is an inhibitory receptor expressed on the surface of NK and T lymphocyte subsets. J. Immunol. 178, 4402-4410.
69. Yusa, S-i., Catina, T. L., Campbell, K. S. (2004) KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2). J. Immunol. 172, 7385-7392.
70. Cella, M., Longo, A., Ferrara, G., Strominger, J., Colonna, M. (1994) NK3-specific natural killer cells are selectively inhibited by Bw4-positive HLA alleles with isoleucine 80. J. Exp. Med. 180, 1235-1242.
71. Rojo, S., Wagtmann, N., Long, E. (1997) Binding of a soluble p70 killer cell inhibitory receptor to HLA-B*5101: requirement for all three p70 immunoglobulin domains. Eur. J. Immunol. 27, 568-571.
72. Malnati, M. S., Peruzzi, M., Parker, K. C., Biddison, W. E., Ciccone, E., Moretta, A., Long, E. O. (1995) Peptide specificity in the recognition of MHC class I by natural killer cell clones. Science 267, 1016-1018.
73. O'Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P., Gardiner, C. M. (2007) Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 178, 235-241.
74. Thananchai, H., Gillespie, G., Martin, M. P., Bashirova, A., Yawata, N., Yawata, M., Easterbrook, P., McVicar, D. W., Maenaka, K., Parham, P., Carrington, M., Dong, T., Rowland-Jones, S. (2007) Cutting edge: allele-specific and peptide-dependent interactions between KIR3DL1 and HLA-A and HLA-B. J. Immunol. 178, 33-37.
75. Martin, M. P., Qi, Y., Gao, X., Yamada, E., Martin, J. N., Pereyra, F., Colombo, S., Brown, E. E., Shupert, W. L., Phair, J., Goedert, J. J., Buchbinder, S., Kirk, G. D., Telenti, A., Connors, M., O'Brien, S. J., Walker, B. D., Parham, P., Deeks, S. G., McVicar, D. W., Carrington, M. (2007) Innate partnership of HLA-B and KIR3DL1 subtypes against HIV-1. Nat. Genet. 39, 733-740.
76. O'Connor, G. M., Guinan, K. J., Cunningham, R. T., Middleton, D., Parham, P., Gardiner, C. M. (2007) Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells. J. Immunol. 178, 235-241.
77. Martin, M. P., Gao, X., Lee, J-H., Nelson, G. W., Detels, R., Goedert, J. J., Buchbinder, S., Hoots, K., Vlahov, D., Trowsdale, J., Wilson, M., O'Brien, S. J., Carrington, M. (2002) Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Genet. 31, 429-434.
78. Carr, W. H., Rosen, D. B., Arase, H., Nixon, D. F., Michaelsson, J., Lanier, L. L. (2007) Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178, 647-651.
79. Khakoo, S. I., Thio, C. L., Martin, M. P., Brooks, C. R., Gao, X., Astemborski, J., Cheng, J., Goedert, J. J., Vlahov, D., Hilgartner, M., Cox, S., Little, A-M., Alexander, G. J., Cramp, M. E., O'Brien, S. J., Rosenberg, W. M. C., Thomas, D. L., Carrington, M. (2004) HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection. Science 305, 872-874.
80. Katz, G., Gazit, R., Arnon, T. I., Gonen-Gross, T., Tarcic, G., Markel, G., Gruda, R., Achdout, H., Drize, O., Merims, S., Mandelboim, O. (2004) MHC class I-independent recognition of NK-activating receptor KIR2DS4. J. Immunol. 173, 1819-1825.
81. Arase, H., Mocarski, E. S., Campbell, A. E., Hill, A. B., Lanier, L. L. (2002) Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296, 1323-1326.
82. Desrosiers, M-P., Kielczewska, A., Loredo-Osti, J. C., Adam, S. G., Makrigiannis, A. P., Lemieux, S., Pham, T., Lodoen, M. B., Morgan, K., Lanier, L. L., Vidal, S. M. (2005) Epistasis between mouse Klra and major histocompatibility complex class I loci is associated with a new mechanism of natural killer cell-mediated innate resistance to cytomegalovirus infection. Nat. Genet. 37, 593-599.
83. Rajagopalan, S., Long, E. O. (1997) The direct binding of a p58 killer cell inhibitory receptor to human histocompatibility leukocyte antigen (HLA)-Cw4 exhibits peptide selectivity. J. Exp. Med. 185, 1523-1528.
84. Liberatore, C., Capanni, M., Albi, N., Volpi, I., Urbani, E., Ruggeri, L., Mencarelli, A., Grignani, F., Velardi, A. (1999) Natural killer cell-mediated lysis of autologous cells modified by gene therapy. J. Exp. Med. 189, 1855-1862.
85. Diefenbach, A., Raulet, D. H. (2001) Strategies for target cell recognition by natural killer cells. Immunol. Rev. 181, 170-184.
86. Kim, D-K., Kabat, J., Borrego, F., Sanni, T. B., You, C-h., Coligan, J. E. (2004) Human NKG2F is expressed and can associate with DAP12. Mol. Immunol. 41, 53-62.
87. Takaki, R., Watson, S. R., Lanier, L. L. (2006) DAP12: an adapter protein with dual functionality. Immunol. Rev. 214, 118-129.
88. Borrego, F., Ulbrecht, M., Weiss, E. H., Coligan, J. E., Brooks, A. G. (1998) Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J. Exp. Med. 187, 813-818.
89. Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Soderstrom, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., Lanier, L. L., McMichael, A. J. (1998) HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391, 795-799.
90. Lee, N., Llano, M., Carretero, M., Ishitani, A., Navarro, F., Lopez-Botet, M., Geraghty, D. E. (1998) HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95, 5199-5204.
91. Leibson, P. J. (1998) Cytotoxic lymphocyte recognition of HLA-E: utilizing a nonclassical window to peer into classical MHC. Immunity 9, 289-294.
92. Vance, R. E., Jamieson, A. M., Raulet, D. H. (1999) Recognition of the class Ib molecule Qa-1b by putative activating receptors CD94/NKG2C and CD94/NKG2E on mouse natural killer cells. J. Exp. Med. 190, 1801-1812.
93. Tomasec, P., Braud, V. M., Rickards, C., Powell, M. B., McSharry, B. P., Gadola, S., Cerundolo, V., Borysiewicz, L. K., McMichael, A. J., Wilkinson, G. W. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287, 1031.
94. Coupel, S., Moreau, A., Hamidou, M., Horejsi, V., Soulillou, J-P., Charreau, B. (2007) Expression and release of soluble HLA-E is an immunoregulatory feature of endothelial cell activation. Blood 109, 2806-2814.
95. Matsumoto, N., Ribaudo, R. K., Abastado, J-P., Margulies, D. H., Yokoyama, W. M. (1998) The lectin-like NK cell receptor Ly-49A recognizes a carbohydrate-independent epitope on its MHC class I ligand. Immunity 8, 245-254.
96. Long, E. O. (2002) Versatile signaling through NKG2D. Nat. Immunol. 3, 1119-1120.
97. Shiroishi, M., Tsumoto, K., Amano, K., Shirakihara, Y., Colonna, M., Braud, V. M., Allan, D. S. J., Makadzange, A., Rowland-Jones, S., Willcox, B., Jones, E. Y., van der Merwe, P. A., Kumagai, I., Maenaka, K. (2003) Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G. Proc. Natl. Acad. Sci. USA 100, 8856-8861.
98. Young, N. T., Uhrberg, M., Phillips, J. H., Lanier, L. L., Parham, P. (2001) Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 166, 3933-3941.
99. Giustiniani, J., Marie-Cardine, A., Bensussan, A. (2007) A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J. Immunol. 178, 1293-1300.
100. Wu, J., Song, Y., Bakker, A. B., Bauer, S., Spies, T., Lanier, L. L., Phillips, J. H. (1999) An activating immunoreceptor complex formed by NKG2D and DAP10. Science 285, 730-732.
101. Markiewicz, M. A., Carayannopoulos, L. N., Naidenko, O. V., Matsui, K., Burack, W. R., Wise, E. L., Fremont, D. H., Allen, P. M., Yokoyama, W. M., Colonna, M., Shaw, A. S. (2005) Costimulation through NKG2D enhances murine CD8+ CTL function: similarities and differences between NKG2D and CD28 costimulation. J. Immunol. 175, 2825-2833.
102. Bauer, S., Groh, V., Wu, J., Steinle, A., Phillips, J. H., Lanier, L. L., Spies, T. (1999) Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 285, 727-729.
103. Stephens, H. A. (2001) MICA and MICB genes: can the enigma of their polymorphism be resolved? Trends Immunol. 22, 378-385.
104. Cerwenka, A., Bakker, A. B. H., McClanahan, T., Wagner, J., Wu, J., Phillips, J. H., Lanier, L. L. (2000) Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity 12, 721-727.
105. Diefenbach, A., Jamieson, A. M., Liu, S. D., Shastri, N., Raulet, D. H. (2000) Ligands for the murine NKG2D receptor: expression by tumor cells and activation of NK cells and macrophages. Nat. Immunol. 1, 119-126.
106. Gasser, S., Orsulic, S., Brown, E. J., Raulet, D. H. (2005) The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature 436, 1186-1190.
107. Groh, V., Rhinehart, R., Randolph-Habecker, J., Topp, M. S., Riddell, S. R., Spies, T. (2001) Costimulation of CD8[α][β] T cells by NKG2D via engagement by MIC induced on virus-infected cells. Nat. Immunol. 2, 255-260.
108. Salih, H. R., Antropius, H., Gieseke, F., Lutz, S. Z., Kanz, L., Rammensee, H-G., Steinle, A. (2003) Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia. Blood 102, 1389-1396.
109. Salih, H. R., Goehlsdorf, D., Steinle, A. (2006) Release of MICB molecules by tumor cells: mechanism and soluble MICB in sera of cancer patients. Hum. Immunol. 67, 188-195.
110. Bashirova, A. A., Martin, M. P., McVicar, D. W., Carrington, M. (2006) The killer immunoglobulin-like receptor gene cluster: tuning the genome for defense. Annu. Rev. Genomics Hum. Genet. 7, 277-300.
111. González, S., Groh, V., Spies, T. (2006) Immunobiology of human NKG2D and its ligands. Curr. Top. Microbiol. Immunol. 298, 121-138.
112. Dhanji, S., Teh, S-J., Oble, D., Priatel, J. J., Teh, H-S. (2004) Self-reactive memory-phenotype CD8 T cells exhibit both MHC-restricted and non-MHC-restricted cytotoxicity: a role for the T-cell receptor and natural killer cell receptors. Blood 104, 2116-2123.
113. Bottino, C., Castriconi, R., Pende, D., Rivera, P., Nanni, M., Carnemolla, B., Cantoni, C., Grassi, J., Marcenaro, S., Reymond, N., Vitale, M., Moretta, L., Lopez, M., Moretta, A. (2003) Identification of PVR (CD155) and nectin-2 (CD112) as cell surface ligands for the human DNAM-1 (CD226) activating molecule. J. Exp. Med. 198, 557-567.
114. Hamerman, J. A., Ogasawara, K., Lanier, L. L. (2004) Cutting edge: Toll-like receptor signaling in macrophages induces ligands for the NKG2D receptor. J. Immunol. 172, 2001-2005.
115. Saikali, P., Antel, J. P., Newcombe, J., Chen, Z., Freedman, M., Blain, M., Cayrol, R., Prat, A., Hall, J. A., Arbour, N. (2007) NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis. J. Neurosci. 27, 1220-1228.
116. Biassoni, R., Cantoni, C., Pende, D., Sivori, S., Parolini, S., Vitale, M., Bottino, C., Moretta, A. (2001) Human natural killer cell receptors and co-receptors. Immunol. Rev. 181, 203-214.
117. Moretta, A., Bottino, C., Vitale, M., Pende, D., Cantoni, C., Mingari, M. C., Biassoni, R., Moretta, L. (2001) Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. Annu. Rev. Immunol. 19, 197-223.
118. Moretta, L., Bottino, C., Pende, D., Vitale, M., Mingari, M. C., Moretta, A. (2004) Different checkpoints in human NK-cell activation. Trends Immunol. 25, 670-676.
119. Arnon, T. I., Achdout, H., Lieberman, N., Gazit, R., Gonen-Gross, T., Katz, G., Bar-Ilan, A., Bloushtain, N., Lev, M., Joseph, A., Kedar, E., Porgador, A., Mandelboim, O. (2004) The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46. Blood 103, 664-672.
120. Gazit, R., Garty, B-Z., Monselise, Y., Hoffer, V., Finkelstein, Y., Markel, G., Katz, G., Hanna, J., Achdout, H., Gruda, R., Gonen-Gross, T., Mandelboim, O. (2004) Expression of KIR2DL1 on the entire NK cell population: a possible novel immunodeficiency syndrome. Blood 103, 1965-1966.
121. Aldemir, H., Prod'homme, V., Dumaurier, M-J., Retiere, C., Poupon, G., Cazareth, J., Bihl, F., Braud, V. M. (2005) Cutting edge: lectin-like transcript 1 is a ligand for the CD161 receptor. J. Immunol. 175, 7791-7795.
122. Mathew, P. A., Chuang, S., Vaidya, S., Kumaresan, P., Boles, K., Pham, H. (2004) The LLT1 receptor induces IFN-γ production by human natural killer cells. Mol. Immunol. 40, 1157-1163.
123. Veillette, A. (2006) NK cell regulation by SLAM family receptors and SAP-related adapters. Immunol. Rev. 214, 22-34.
124. Nichols, K. E., Hom, J., Gong, S-Y., Ganguly, A., Ma, C. S., Cannons, J. L., Tangye, S. G., Schwartzberg, P. L., Koretzky, G. A., Stein, P. L. (2005) Regulation of NKT cell development by SAP, the protein defective in XLP. Nat. Med. 11, 340-345.
125. Benoit, L., Wang, X., Pabst, H. F., Dutz, J., Tan, R. (2000) Cutting edge: defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol. 165, 3549-3553.
126. Parolini, S., Bottino, C., Falco, M., Augugliaro, R., Giliani, S., Franceschini, R., Ochs, H. D., Wolf, H., Bonnefoy, J-Y., Biassoni, R., Moretta, L., Notarangelo, L. D., Moretta, A. (2000) X-linked lymphoproliferative disease: 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells. J. Exp. Med. 192, 337-346.
127. Eissmann, P., Watzl, C. (2006) Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells. J. Immunol. 177, 3170-3177.
128. Ibegbu, C. C., Xu, Y-X., Harris, W., Maggio, D., Miller, J. D., Kourtis, A. P. (2005) Expression of killer cell lectin-like receptor G1 on antigen-specific human CD8+ T lymphocytes during active, latent, and resolved infection and its relation with CD57. J. Immunol. 174, 6088-6094.
129. Ito, M., Ishida, T., He, L., Tanabe, F., Rongge, Y., Miyakawa, Y., Terunuma, H. (1998) HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 14, 845-849.
130. Wilson, C. C., Kalams, S., Wilkes, B., Ruhl, D., Gao, F., Hahn, B., Hanson, I., Luzuriaga, K., Wolinsky, S., Koup, R., Buchbinder, S., Johnson, R., Walker, B. (1997) Overlapping epitopes in human immunodeficiency virus type 1 gp120 presented by HLA A, B, and C molecules: effects of viral variation on cytotoxic T-lymphocyte recognition. J. Virol. 71, 1256-1264.
131. Welte, S., Kuttruff, S., Waldhauer, I., Steinle, A. (2006) Mutual activation of natural killer cells and monocytes mediated by NKp80-AICL interaction. Nat. Immunol. 7, 1334-1342.
132. Saudemont, A., Jouy, N., Hetuin, D., Quesnel, B. (2005) NK cells that are activated by CXCL10 can kill dormant tumor cells that resist CTL-mediated lysis and can express B7-H1 that stimulates T cells. Blood 105, 2428-2435.
133. Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M-R., Delwart, E., Sepulveda, H., Balderas, R. S., Routy, J-P., Haddad, E. K., Sekaly, R-P. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198-1202.
134. Stern, N., Markel, G., Arnon, T. I., Gruda, R., Wong, H., Gray-Owen, S. D., Mandelboim, O. (2005) Carcinoembryonic antigen (CEA) inhibits NK killing via interaction with CEA-related cell adhesion molecule 1. J. Immunol. 174, 6692-6701.
135. Berman, M. E., Xie, Y., Muller, W. (1996) Roles of platelet/endothelial cell adhesion molecule-1 (PECAM-1, CD31) in natural killer cell transendothelial migration and β 2 integrin activation. J. Immunol. 156, 1515-1524.
136. Barber, D. F., Faure, M., Long, E. O. (2004) LFA-1 contributes an early signal for NK cell cytotoxicity. J. Immunol. 173, 3653-3659.
137. Bryceson, Y. T., March, M. E., Ljunggren, H-G., Long, E. O. (2006) Activation, coactivation, and costimulation of resting human natural killer cells. Immunol. Rev. 214, 73-91.
138. Pittet, M. J., Speiser, D. E., Valmori, D., Cerottini, J-C., Romero, P. (2000) Cutting edge: cytolytic effector function in human circulating CD8+ T cells closely correlates with CD56 surface expression. J. Immunol. 164, 1148-1152.
139. Kärre, K., Ljunggren, H. G., Piontek, G., Kiessling, R. (1986) Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defense strategy. Nature 319, 675-678.
140. Raulet, D. H., Vance, R. E., McMahon, C. W. (2001) Regulation of the natural killer cell repertoire. Annu. Rev. Immunol. 19, 291-330.
141. Stulberg, M. J., Wright, P. W., Dang, H., Hanson, R. J., Miller, J. S., Anderson, S. K. (2006) Identification of distal KIR promoters and transcripts. Genes Immun. 8, 124-130.
142. Hammond, S. M. (2005) Dicing and slicing: the core machinery of the RNA interference pathway. FEBS Lett. 579, 5822-5829.
143. Davies, G. E., Locke, S. M., Wright, P. W., Li, H., Hanson, R. J., Miller, J. S., Anderson, S. K. (2007) Identification of bidirectional promoters in the human KIR genes. Genes Immun. 8, 245-253.
144. Pascal, V., Stulberg, M. J., Anderson, S. K. (2006) Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough! Immunol. Rev. 214, 9-21.
145. Vilches, C., Gardiner, C. M., Parham, P. (2000) Gene structure and promoter variation of expressed and nonexpressed variants of the KIR2DL5 gene. J. Immunol. 165, 6416-6421.
146. Kubota, A., Kubota, S., Lohwasser, S., Mager, D. L., Takei, F. (1999) Diversity of NK cell receptor repertoire in adult and neonatal mice. J. Immunol. 163, 212-216.
147. Uhrberg, M., Valiante, N. M., Shum, B. P., Shilling, H. G., Lienert-Weidenbach, K., Corliss, B., Tyan, D., Lanier, L. L., Parham, P. (1997) Human diversity in killer cell inhibitory receptor genes. Immunity 7, 753-763.
148. Valiante, N. M., Uhrberg, M., Shilling, H. G., Lienert-Weidenbach, K., Arnett, K. L., D'Andrea, A., Phillips, J. H., Lanier, L. L., Parham, P. (1997) Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity 7, 739-751.
149. Yawata, M., Yawata, N., Draghi, M., Little, A-M., Partheniou, F., Parham, P. (2006) Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function. J. Exp. Med. 203, 633-645.
150. Shilling, H. G., Young, N., Guethlein, L. A., Cheng, N. W., Gardiner, C. M., Tyan, D., Parham, P. (2002) Genetic control of human NK cell repertoire. J. Immunol. 169, 239-247.
151. Sivori, S., Cantoni, C., Parolini, S., Marcenaro, E., Conte, R., Moretta, L., Moretta, A. (2003) IL-21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors. Eur. J. Immunol. 33, 3439-3447.
152. Bertone, S., Schiavetti, F., Bellomo, R., Vitale, C., Ponte, M., Moretta, L., Mingari, M. C. (1999) Transforming growth factor β-induced expression of CD94/NKG2A inhibitory receptors in human T lymphocytes. Eur. J. Immunol. 29, 23-29.
153. Burgess, S. J., Marusina, A. I., Pathmanathan, I., Borrego, F., Coligan, J. E. (2006) IL-21 down-regulates NKG2D/DAP10 expression on human NK and CD8+ T cells. J. Immunol. 176, 1490-1497.
154. Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., Moretta, A. (2003) Transforming growth factor β 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA 100, 4120-4125.
155. Mingari, M. C., Vitale, C., Cantoni, C., Bellomo, R., Ponte, M., Schiavetti, F., Bertone, S., Moretta, A., Moretta, L. (1997) Interleukin-15-induced maturation of human natural killer cells from early thymic precursors: selective expression of CD94/NKG2-A as the only HLA class I-specific inhibitory receptor. Eur. J. Immunol. 27, 1374-1380.
156. Mingari, M. C., Ponte, M., Bertone, S., Schiavetti, F., Vitale, C., Bellomo, R., Moretta, A., Moretta, L. (1998) HLA class I-specific inhibitory receptors in human T lymphocytes: interleukin 15-induced expression of CD94/NKG2A in superantigen- or alloantigen-activated CD8+ T cells. Proc. Natl. Acad. Sci. USA 95, 1172-1177.
157. Tajima, K., Matsumoto, N., Ohmori, K., Wada, H., Ito, M., Suzuki, K., Yamamoto, K. (2004) Augmentation of NK cell-mediated cytotoxicity to tumor cells by inhibitory NK cell receptor blockers. Int. Immunol. 16, 385-393.
158. Fernandez, N. C., Treiner, E., Vance, R. E., Jamieson, A. M., Lemieux, S., Raulet, D. H. (2005) A subset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood 105, 4416-4423.
159. Kim, S., Poursine-Laurent, J., Truscott, S. M., Lybarger, L., Song, Y-J., Yang, L., French, A. R., Sunwoo, J. B., Lemieux, S., Hansen, T. H., Yokoyama, W. M. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436, 709-713.
160. Yokoyama, W. M., Kim, S. (2006) How do natural killer cells find self to achieve tolerance? Immunity 24, 249-257.
161. Gasser, S., Raulet, D. H. (2006) Activation and self-tolerance of natural killer cells. Immunol. Rev. 214, 130-142.
162. Oppenheim, D. E., Roberts, S. J., Clarke, S. L., Filler, R., Lewis, J. M., Tigelaar, R. E., Girardi, M., Hayday, A. C. (2005) Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat. Immunol. 6, 928-937.
163. Parham, P. (2005) Immunogenetics of killer cell immunoglobulin-like receptors. Mol. Immunol. 42, 459-462.
164. Yawata, M., Yawata, N., Abi-Rached, L., Parham, P. (2002) Variation within the human killer cell immunoglobulin-like receptor (KIR) gene family. Crit. Rev. Immunol. 22, 463-482.
165. Maxwell, L. D., Wallace, A., Middleton, D., Curran, M. D. (2002) A common KIR2DS4 deletion variant in the human that predicts a soluble KIR molecule analogous to the KIR1D molecule observed in the rhesus monkey. Tissue Antigens 60, 254-258.
166. Yawata, M., Yawata, N., McQueen, K., Cheng, N., Guethlein, L., Rajalingam, R., Shilling, H., Parham, P. (2002) Predominance of group A KIR haplotypes in Japanese associated with diverse NK cell repertoires of KIR expression. Immunogenetics 54, 543-550.
167. Hiby, S. E., Walker, J. J., O'Shaughnessy, K. M., Redman, C. W. G., Carrington, M., Trowsdale, J., Moffett, A. (2004) Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success. J. Exp. Med. 200, 957-965.
168. Du, Z., Gjertson, D., Reed, E., Rajalingam, R. (2007) Receptor-ligand analyses define minimal killer cell Ig-like receptor (KIR) in humans. Immunogenetics 59, 1-15.
169. van der Slik, A. R., Alizadeh, B., Koeleman, B., Roep, B., Giphart, M. (2007) Modelling KIR-HLA genotype disparities in type 1 diabetes. Tissue Antigens 69, 101-105.
170. van der Slik, A. R., Koeleman, B. P. C., Verduijn, W., Bruining, G. J., Roep, B. O., Giphart, M. J. (2003) KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects. Diabetes 52, 2639-2642.
171. López-Larrea, C., Njobvu, P. D., González, S., Blanco-Gelaz, M. A., Martínez-Borra, J., López-Vázquez, A. (2005) The HLA-B*5703 allele confers susceptibility to the development of spondylarthropathies in Zambian human immunodeficiency virus-infected patients with slow progression to acquired immunodeficiency syndrome. Arthritis Rheum. 52, 275-279.
172. Altfeld, M., Kalife, E. T., Qi, Y., Streeck, H., Lichterfeld, M., Johnston, M. N., Burgett, N., Swartz, M. E., Yang, A., Alter, G., Yu, X. G., Meier, A., Rockstroh, J. K., Allen, T. M., Jessen, H., Rosenberg, E. S., Carrington, M., Walker, B. D. (2006) HLA alleles associated with delayed progression to AIDS contribute strongly to the initial CD8+ T cell response against HIV-1. PLoS Med. 3, e403.
173. Carrington, M., O'Brien, S. J. (2003) The influence of HLA genotype on AIDS. Annu. Rev. Med. 54, 535-551.
174. Heeney, J. L., Plotkin, S. A. (2006) Immunological correlates of protection from HIV infection and disease. Nat. Immunol. 7, 1281-1284.
175. McMichael, A. J., Rowland-Jones, S. L. (2001) Cellular immune responses to HIV. Nature 410, 980-987.
176. Flores-Villanueva, P. O., Yunis, E. J., Delgado, J. C., Vittinghoff, E., Buchbinder, S., Leung, J. Y., Uglialoro, A. M., Clavijo, O. P., Rosenberg, E. S., Kalams, S. A., Braun, J. D., Boswell, S. L., Walker, B. D., Goldfeld, A. E. (2001) Control of HIV-1 viremia and protection from AIDS are associated with HLA-Bw4 homozygosity. Proc. Natl. Acad. Sci. USA 98, 5140-5145.
177. Qi, Y., Martin, M. P., Gao, X., Jacobson, L., Goedert, J. J., Buchbinder, S., Kirk, G. D., Brien, S. J., Trowsdale, J., Carrington, M. (2006) KIR/HLA pleiotropism: protection against both HIV and opportunistic infections. PLoS Pathog. 2, e79.
178. Gaudieri, S., DeSantis, D., McKinnon, E., Moore, C., Nolan, D., Witt, C. S., Mallal, S. A., Christiansen, F. T. (2005) Killer immunoglobulin-like receptors and HLA act both independently and synergistically to modify HIV disease progression. Genes Immun. 6, 683-690.
179. Gaudieri, S., Nolan, D., McKinnon, E., Witt, C. S., Mallal, S., Christiansen, F. T. (2005) Associations between KIR epitope combinations expressed by HLA-B/-C haplotypes found in an HIV-1 infected study population may influence NK mediated immune responses. Mol. Immunol. 42, 557-560.
180. Lopez-Vazquez, A., Mina-Blanco, A., Martinez-Borra, J., Njobvu, P. D., Suarez-Alvarez, B., Blanco-Gelaz, M. A., Gonzalez, S., Rodrigo, L., Lopez-Larrea, C. (2005) Interaction between KIR3DL1 and HLA-B*57 supertype alleles influences the progression of HIV-1 infection in a Zambian population. Hum. Immunol. 66, 285-289.
181. Martin, M., Pascal, V., Yeager, M., Phair, J., Kirk, G., Hoots, K., O'Brien, S., Anderson, S., Carrington, S. (2007) A mutation in KIR3DS1 that results in truncation and lack of cell surface expression. Immunogenetics 59, 823-829.
182. Pascal, V., Yamada, E., Martin, M. P., Alter, G., Altfeld, M., Metcalf, J. A., Baseler, M. W., Adelsberger, J. W., Carrington, M., Anderson, S. K., McVicar, D. W. (2007) Detection of KIR3DS1 on the cell surface of peripheral blood NK cells facilitates identification of a novel null allele and assessment of KIR3DS1 expression during HIV-1 infection. J. Immunol. 179, 1625-1633.
183. Jennes, W., Verheyden, S., Demanet, C., Adje-Toure, C. A., Vuylsteke, B., Nkengasong, J. N., Kestens, L. (2006) Cutting edge: resistance to HIV-1 infection among African female sex workers is associated with inhibitory KIR in the absence of their HLA ligands. J. Immunol. 177, 6588-6592.
184. Zhou, H., Luo, Y., Lo, J-f., Kaplan, C. D., Mizutani, M., Mizutani, N., Lee, J-D., Primus, F. J., Becker, J. C., Xiang, R., Reisfeld, R. A. (2005) DNA-based vaccines activate innate and adaptive antitumor immunity by engaging the NKG2D receptor. Proc. Natl. Acad. Sci. USA 102, 10846-10851.
185. Ravet, S., Scott-Algara, D., Bonnet, E., Tran, H. K., Tran, T., Nguyen, N., Truong, L. X., Theodorou, I., Barre-Sinoussi, F., Pancino, G., Paul, P. (2007) Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals. Blood 109, 4296-4305.
186. Scott-Algara, D., Truong, L. X., Versmisse, P., David, A., Luong, T. T., Nguyen, N. V., Theodorou, I., Barre-Sinoussi, F., Pancino, G. (2003) Cutting edge: increased NK cell activity in HIV-1-exposed but uninfected Vietnamese intravascular drug users. J. Immunol. 171, 5663-5667.
187. Barbour, J. D., Sriram, U., Caillier, S. J., Levy, J. A., Hecht, F. M., Oksenberg, J. R. (2007) Synergy or independence? Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression. PLoS Pathog. 3, e43.
188. Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H., Waring, M., Meier, A., Brander, C., Lifson, J. D., Allen, T. M., Carrington, M., Altfeld, M. (2007) Differential natural killer cell mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes. J. Exp. Med. 204, 3027-3036.
189. Maenaka, K., Juji, T., Nakayama, T., Wyer, J. R., Gao, G. F., Maenaka, T., Zaccai, N. R., Kikuchi, A., Yabe, T., Tokunaga, K., Tadokoro, K., Stuart, D. I., Jones, E. Y., van der Merwe, P. A. (1999) Killer cell immunoglobulin receptors and T cell receptors bind peptide-major histocompatibility complex class I with distinct thermodynamic and kinetic properties. J. Biol. Chem. 274, 28329-28334.
190. Sawicki, M. W., Dimasi, N., Natarajan, K., Wang, J., Margulies, D. H., Mariuzza, R. A. (2001) Structural basis of MHC class I recognition by natural killer cell receptors. Immunol. Rev. 181, 52-65.
191. Trundley, A., Frebel, H., Jones, D., Chang, C., Trowsdale, J. (2007) Allelic expression patterns of KIR3DS1 and 3DL1 using the Z27 and DX9 antibodies. Eur. J. Immunol. 37, 780-787.
192. Matte, C., Lajoie, J., Lacaille, J., Zijenah, L., Ward, B., Roger, M. (2004) Functionally active HLA-G polymorphisms are associated with the risk of heterosexual HIV-1 infection in African women. AIDS 18, 427-431.
193. Lajoie, J., Hargrove, J., Zijenah, L. S., Humphrey, J. H., Ward, B. J., Roger, M. (2006) Genetic variants in nonclassical major histocompatibility complex class I human leukocyte antigen (HLA)-E and HLA-G molecules are associated with susceptibility to heterosexual acquisition of HIV-1. J. Infect. Dis. 193, 298-301.
194. Boulet, S., Sharafi, S., Simic, N., Bruneau, J., Routy, J. P., Tsoukas, C. M., Bernard, N. F. (2008) Increased proportion of KIR3DS1 homozygotes in HIV-exposed uninfected individuals. AIDS 22, 595-599.